ABOPM Seal
Donate Today Log In
American Board of Precision Medicine Blogs
The Future of Medicine Starts Here
Stay ahead with expert perspectives on precision medicine, clinical innovation, and the technologies transforming healthcare.

Liquid Biopsy and Early Cancer Detection: Promise and Limitations

by: ABOPM TeamPublished on: 05/06/2026

Liquid biopsy is transforming cancer detection through minimally invasive genomic testing, offering new opportunities for earlier diagnosis and monitoring.

Precision Oncology
Liquid Biopsy and Early Cancer Detection: Promise and Limitations

Precision Medicine in Oncology Isn’t the Future - It’s Already Late

Precision Medicine in Oncology Isn’t the Future - It’s Already Lateby: Shraddha HakaniPublished on: 17/05/2026

Precision medicine in oncology is no longer a distant vision- it is a critical necessity. As cancer care evolves, biomarker-driven diagnostics, genomic sequencing, digital pathology, and AI-powered insights are transforming how clinicians detect.

Precision Oncology
Precision Medicine in Oncology Isn’t the Future - It’s Already Late

A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.

FOLLOW US

LEARN ABOUT THE

ABOPM

CUSTOMER CARE

LEGAL

Copyright 2026. American Board of Precision Medicine. All Rights Reserved.